Compounds > 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
Page last updated: 2024-09-03

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Astrocytoma

3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Astrocytoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donnelly-Roberts, DL; Han, P; Jarvis, MF; Namovic, MT1
Haas, M; Reiser, G; Shaaban, A1
Carroll, WA; Donnelly-Roberts, DL; Jarvis, MF; Namovic, MT; Perez-Medrano, A; Surber, B; Vaidyanathan, SX; Wang, Y1
Carroll, WA; Chu, KL; Donnelly-Roberts, DL; Fabiyi, AC; Faltynek, CR; Gauvin, DM; Gregg, RJ; Harris, RR; Honore, P; Jarvis, MF; Kort, ME; Marsh, K; McGaraughty, S; Namovic, MT; Nelson, DW; Shieh, CC; Wismer, CT; Zhang, XF; Zhu, CZ1

Other Studies

4 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Astrocytoma

ArticleYear
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.
    British journal of pharmacology, 2009, Volume: 157, Issue:7

    Topics: Animals; Astrocytoma; Benzoxazoles; Calcium; Cell Line, Tumor; Fluorescent Dyes; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Species Specificity

2009
Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
    Journal of neurochemistry, 2014, Volume: 129, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Astrocytoma; Autoimmunity; Brain; Calcium Signaling; Cell Line, Tumor; Cyclic AMP; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Polymorphism, Single Nucleotide; Protein Interaction Mapping; Purinergic Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Structure-Activity Relationship; Thionucleotides; Transfection

2014
[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
    Neuropharmacology, 2009, Volume: 56, Issue:1

    Topics: Adenosine Triphosphate; Animals; Astrocytoma; Benzoxazoles; Binding, Competitive; Calcium; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Drug; Guanidines; Humans; Inhibitory Concentration 50; Interleukin-1beta; Mice; Purinergic P2 Receptor Antagonists; Quinolines; Quinolinium Compounds; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recombinant Proteins; Transfection; Tritium

2009
P2X7-related modulation of pathological nociception in rats.
    Neuroscience, 2007, Jun-08, Volume: 146, Issue:4

    Topics: Action Potentials; Adenosine Triphosphate; Analgesics; Animals; Astrocytoma; Behavior, Animal; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Humans; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Neurons; Pain Measurement; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Sciatica; Tetrazoles; Time Factors

2007